MitraClip Mitral Valve Repair

When Mitral Valve Leakage Starts to Limit Daily Life

Learning that you have a leaking heart valve can be unsettling, especially if symptoms such as shortness of breath, fatigue, or swelling are beginning to affect ordinary routines. Many people with mitral regurgitation worry about what comes next. They may have been told they need treatment but are concerned about open-heart surgery, age, other medical conditions, or whether their heart is becoming weaker over time. For some, the uncertainty is as difficult as the symptoms themselves.

MitraClip mitral valve repair is often considered in exactly these situations. It offers a less invasive option for selected patients with significant mitral regurgitation, particularly when conventional surgery may carry higher risk or may not be the preferred first approach. The goal is not simply to treat an abnormal valve image on a scan. It is to reduce the backward leak of blood through the mitral valve so the heart can work more efficiently and symptoms may improve.

Timely treatment matters because mitral regurgitation can gradually strain the heart and lungs. Some people adjust to their symptoms so slowly that they do not realize how much their stamina has changed. Others notice a more rapid decline, with increasing breathlessness, repeated hospital visits for heart failure, or difficulty lying flat at night. In the right patient, a catheter-based mitral valve repair can relieve this burden without the recovery associated with open surgery.

For international patients, the decision often includes another layer of questions: How do I know whether I am a candidate? What testing is needed? How long would I need to stay in the hospital and in the country? Would a team review my case before I travel? These are important concerns, and they are best answered through a structured evaluation by cardiologists, interventional cardiologists, cardiac surgeons, imaging specialists, anesthesiologists, and specialized nursing teams working together.

What MitraClip Mitral Valve Repair Is

MitraClip mitral valve repair is a minimally invasive procedure used to treat certain types of mitral regurgitation. The mitral valve sits between the left atrium and the left ventricle, the two chambers on the left side of the heart. Normally, it opens to allow blood to move forward and closes tightly to prevent backflow. In mitral regurgitation, the valve does not close properly, and some blood leaks backward with each heartbeat.

The MitraClip procedure repairs the valve without removing it and without opening the chest through traditional heart surgery. A small clip is delivered to the mitral valve using a catheter, usually inserted through a vein in the groin. The clip grasps and brings together part of the valve leaflets, creating a better seal and reducing the amount of leakage. This technique is sometimes described as an edge-to-edge repair.

The procedure does not treat every form of mitral valve disease. It is used in carefully selected patients based on the structure of the valve, the cause of the leak, overall heart function, symptoms, and the patient’s surgical risk profile. In some cases, mitral regurgitation is caused by a problem with the valve itself, such as degenerative changes. In others, the valve leaks because the left ventricle has enlarged or weakened, pulling the valve structures apart. These differences matter because they influence whether MitraClip is appropriate and how much benefit a patient may receive.

MitraClip is not the same as valve replacement. It preserves the native valve and is designed to reduce regurgitation rather than fully reconstruct the valve anatomy in the way open surgery sometimes can. For many patients, especially those with significant symptoms and elevated risk for surgical intervention, that distinction is clinically meaningful. A less invasive approach may make treatment possible when surgery would otherwise be deferred or avoided.

Who May Need MitraClip Mitral Valve Repair

Patients considered for MitraClip usually have moderate-to-severe or severe mitral regurgitation that is causing symptoms, affecting heart function, or contributing to recurrent heart failure. The most common symptoms include shortness of breath during exertion or at rest, reduced exercise tolerance, unusual fatigue, palpitations, swelling in the legs or ankles, and episodes of fluid buildup that may require hospital treatment. Some patients also experience a persistent cough, trouble sleeping flat, or a sense that ordinary activities now require much more effort.

Not everyone with mitral regurgitation has symptoms right away. Some people are diagnosed after a heart murmur is heard during a physical exam or after an echocardiogram is performed for another reason. Even without obvious symptoms, significant valve leakage can still affect the heart over time. This is why detailed assessment is important, especially when imaging suggests the leak is severe or when the left ventricle begins to enlarge or weaken.

Diagnosis generally starts with a clinical evaluation and echocardiography. Transthoracic echocardiography is often the first imaging test, and transesophageal echocardiography provides a more detailed view of the valve anatomy, the direction and severity of the leak, and whether the valve leaflets appear suitable for clipping. Additional testing may include electrocardiography, blood tests, chest imaging, cardiac CT in selected cases, and coronary angiography or other assessment of the heart’s blood supply when indicated.

Doctors also assess how well the rest of the heart is functioning. They look at left ventricular size and pumping ability, pressure in the lungs, the presence of atrial fibrillation, kidney function, frailty, lung disease, and other medical conditions that can affect both procedural safety and expected benefit. For patients with functional mitral regurgitation, it is especially important to understand whether guideline-directed heart failure treatment has already been optimized, since medication and device therapy remain central parts of care.

Typical situations that may lead to consideration of MitraClip include:

• Significant degenerative mitral regurgitation in a patient whose risk for open-heart surgery is considered high or prohibitive
• Functional or secondary mitral regurgitation related to heart failure despite optimized medical treatment
• Persistent symptoms such as breathlessness and fatigue that limit quality of life
• Repeated hospitalizations for heart failure in the setting of mitral valve leakage
• Patients who need a less invasive treatment approach because of age, prior surgery, lung disease, kidney disease, or other serious medical conditions

Candidacy is not determined by one test alone. The decision depends on whether the anatomy is favorable, whether symptoms are truly related to the valve problem, and whether reducing the leak is likely to improve functional status or reduce heart failure burden. This is why specialist review is a key part of the pathway.

Conditions and Indications It Addresses

MitraClip is primarily used to treat clinically significant mitral regurgitation. Broadly, the condition falls into two main categories, and understanding the difference helps clarify who may benefit most.

Degenerative mitral regurgitation, also called primary mitral regurgitation, occurs when the valve itself is abnormal. The leaflets may prolapse, flail, thicken, or lose their normal support. In these patients, surgery is often the standard treatment when operative risk is acceptable, because surgical repair can provide durable correction in appropriate anatomy. However, when surgery is considered too risky or unsuitable, MitraClip may offer an effective less invasive alternative for symptom relief and reduction of regurgitation.

Functional mitral regurgitation, also called secondary mitral regurgitation, occurs when the valve structure is relatively normal but the heart muscle has enlarged or weakened, preventing the valve from closing properly. This is commonly seen in patients with cardiomyopathy or chronic heart failure. In these cases, MitraClip may be considered when symptoms persist despite optimized medical therapy and when the anatomical and clinical profile suggests the patient may benefit from valve repair.

The procedure may be appropriate in selected patients with:

• Severe symptomatic primary mitral regurgitation when surgical risk is elevated
• Symptomatic secondary mitral regurgitation associated with heart failure despite evidence-based medical treatment
• Recurrent heart failure admissions related in part to mitral valve leakage
• Reduced quality of life caused by valve-related symptoms

It is not suitable for every patient with mitral valve disease. Some may require surgery instead, particularly if they have complex anatomy, extensive calcification, associated valve disease needing correction, active infection, or structural issues that cannot be adequately treated with a clip-based approach. Others may need a different transcatheter strategy or continued medical management. A careful imaging review helps distinguish among these possibilities.

How MitraClip Mitral Valve Repair Is Performed

The MitraClip pathway begins before the day of the procedure. Pre-procedural planning is essential. Patients usually undergo detailed echocardiographic imaging to define valve anatomy and quantify the severity of regurgitation. The care team reviews current medications, kidney function, blood counts, heart rhythm, and any history of bleeding or blood clots. In many cases, anticoagulants or certain diabetes medications need temporary adjustment before the procedure. International patients are often evaluated in advance through secure review of medical records and imaging so the team can determine whether travel for treatment is appropriate.

On the day of the procedure, the patient is admitted to the hospital and prepared in a specialized cardiac catheterization or hybrid procedure suite. An intravenous line is placed, monitoring equipment is connected, and the anesthesia team reviews the plan. MitraClip is commonly performed under general anesthesia or deep sedation, depending on the patient and the procedural approach. Continuous imaging and hemodynamic monitoring are used throughout.

The procedure typically starts with access through a vein in the groin. Unlike open-heart surgery, no large chest incision is required. A catheter is advanced through the venous system to the right atrium. The team then performs a transseptal puncture, which means crossing the thin wall between the right and left atria to reach the left side of the heart. This step requires precision and is guided by advanced imaging.

Real-time transesophageal echocardiography is central to the procedure. It allows the team to visualize the valve leaflets, the direction of the leak, the position of the delivery system, and the effect of the clip once it is placed. Fluoroscopic imaging is also used to track catheter movement and support accurate device positioning. Together, these imaging tools help reduce uncertainty and allow continuous assessment during each stage of repair.

Once the delivery catheter is positioned above the mitral valve, the clip is carefully advanced into place. The operator aligns it with the area of greatest regurgitation and then captures the valve leaflets. Before final release, the team confirms several things: that the clip has securely grasped the leaflets, that the degree of regurgitation has been reduced meaningfully, and that the valve opening remains adequate so that a new obstruction is not created. In some patients, more than one clip may be needed to achieve an acceptable result, depending on anatomy and the pattern of leakage.

After the clip is released, the catheters are withdrawn and the puncture site in the groin is closed. Patients are then transferred to a monitored recovery area or cardiac intensive observation setting. The procedure duration varies, largely depending on valve anatomy, imaging complexity, and whether one or multiple clips are used. Many procedures are completed within a few hours, though the full care process includes preparation and post-procedural monitoring.

Technology plays an important role, but its value lies in how it supports clinical judgment. High-resolution echocardiography helps determine whether the valve is suitable for repair and guides leaflet capture in real time. Catheter-based delivery systems allow access to the heart through the blood vessels rather than through open surgery. Advanced monitoring helps the team assess pressure changes, heart rhythm, oxygenation, and the immediate physiological effect of reducing mitral regurgitation. In experienced hands, these tools contribute to safer planning and more individualized treatment.

Recovery after MitraClip is usually shorter than after open-heart surgery. Many patients begin sitting up and walking within a relatively short time once the groin access site is stable and monitoring is complete. Hospital stay is often brief, although this varies depending on age, overall health, heart failure severity, kidney function, rhythm issues, and how the patient feels after the procedure. Before discharge, the team typically performs follow-up echocardiography, reviews medications, and provides instructions about activity, wound care, and follow-up appointments.

Patients often ask how soon they may feel better. Some notice improvement in breathing or stamina within days to weeks, while for others the change is more gradual as the heart adapts and heart failure treatment continues. Symptom relief depends not only on the valve repair itself but also on baseline heart function and other medical conditions. The procedure is one part of a broader treatment plan, not a replacement for ongoing cardiology care.

Why Acting Early Matters

Mitral regurgitation is not always an emergency, but waiting too long can narrow treatment options and affect results. A leaking mitral valve places chronic volume stress on the left side of the heart. Over time, the left ventricle may enlarge and weaken. Pressure can build up in the lungs, leading to worsening breathlessness and, in some patients, pulmonary hypertension. Irregular heart rhythms such as atrial fibrillation may also develop or become harder to control.

In patients with heart failure, significant secondary mitral regurgitation can create a cycle in which the failing ventricle worsens the leak, and the leak in turn increases the workload on the heart. This may contribute to repeated hospitalizations, declining exercise capacity, and progressive symptoms despite medication. Once heart damage becomes advanced, even successful reduction of the leak may not fully reverse the effects of longstanding strain.

Acting early does not mean rushing into a procedure without proper evaluation. It means recognizing symptoms, obtaining the right imaging, and reviewing the case before the condition progresses further. For patients who are potential MitraClip candidates, timely assessment can help identify the best window for intervention, when symptom improvement and functional benefit may be more likely.

Potential Benefits of Treatment

For appropriately selected patients, MitraClip can offer meaningful clinical advantages:

Benefit	What It Means for You
Reduced mitral regurgitation	Less backward blood flow through the valve may help the heart pump more efficiently and reduce strain on the lungs.
Improvement in symptoms	Many patients experience less shortness of breath, better stamina, and greater ability to perform daily activities.
Less invasive than open-heart surgery	The procedure is performed through a vein in the groin, avoiding a large chest incision and generally allowing a shorter recovery.
Option for higher-risk patients	It may make treatment possible for people who are not good candidates for conventional surgery because of age or other medical conditions.
Support for broader heart failure care	In selected patients with secondary mitral regurgitation, reducing the leak can complement medication and other heart failure therapies.

Typical Recovery Timeline

Recovery varies by age, heart function, and underlying health, but the following general timeline is often helpful:

Time Period	What Patients Can Expect
Day 1	Monitoring in the hospital, assessment of the groin access site, follow-up imaging, and gradual return to sitting up and walking.
First Week	Most patients focus on rest, light activity, medication adjustment, and watching for symptoms such as bleeding, fever, or increasing shortness of breath.
First Month	Energy levels often improve progressively. Follow-up with the cardiology team helps confirm valve function and optimize ongoing treatment.
Longer Term	Continued heart care remains important, especially in patients with heart failure or rhythm disorders. Periodic echocardiography is usually part of long-term follow-up.

What Influences Outcomes and a Good Result

Results after MitraClip depend on several interacting factors. One of the most important is patient selection. The best outcomes are generally seen when the valve anatomy is suitable for clip placement and when the symptoms or heart failure burden are truly related to mitral regurgitation. Careful imaging before the procedure is therefore essential, not optional.

The underlying cause of the leak also matters. Patients with degenerative mitral regurgitation and favorable anatomy may experience significant symptom improvement when the leak is reduced effectively. In secondary mitral regurgitation, outcomes are often more closely tied to the severity of the underlying heart failure and how well medical therapy has been optimized. The clip can reduce one important burden on the heart, but it does not cure cardiomyopathy.

Other factors that influence recovery and long-term benefit include:

• The degree to which regurgitation is reduced during the procedure
• Baseline left ventricular function and size
• Presence of pulmonary hypertension
• Kidney function and other major medical conditions
• Frailty and general physical reserve
• Heart rhythm disorders such as atrial fibrillation
• Adherence to medications and follow-up care after the procedure

Operator and center experience are also relevant. MitraClip requires technical skill, but equally important is the judgment involved in selecting patients, interpreting imaging, managing anesthesia and hemodynamics, and responding to findings during the procedure. Centers that use structured heart team evaluation are often better positioned to match the treatment approach to the patient rather than trying to fit every patient into a single strategy.

Why International Patients Choose Acibadem for This Evaluation and Treatment

For international patients considering MitraClip, the quality of the decision-making process is just as important as the procedure itself. At Acibadem, patients are evaluated within an integrated cardiology and cardiac surgery framework that brings together interventional cardiologists, cardiac surgeons, cardiac imaging specialists, anesthesiologists, heart failure experts, and specialized nursing teams. Complex valve cases can be reviewed by multidisciplinary boards so that treatment recommendations reflect both anatomical detail and the patient’s broader medical picture.

This matters because transcatheter mitral repair is not the right answer for everyone. Some patients benefit most from MitraClip. Others may be better served by surgery, medical optimization, rhythm treatment, or a different structural heart intervention. A careful team-based review helps ensure that the recommendation is based on evidence, imaging findings, symptom burden, and procedural risk rather than on a one-size-fits-all pathway.

Acibadem hospitals are JCI-accredited and support advanced cardiac diagnostics and catheter-based therapies within comprehensive hospital settings. For patients traveling from abroad, this can be important when a valve procedure is being considered in the context of multiple health issues such as coronary disease, arrhythmia, diabetes, kidney impairment, or prior cardiac surgery. Access to coordinated inpatient care, intensive monitoring when needed, and specialist consultation across disciplines can make the overall treatment journey more organized and clinically sound.

Modern diagnostic pathways also support international care. Echocardiography, transesophageal imaging, cardiac CT when indicated, catheter-based assessment, and pre-anesthesia evaluation are used not as isolated tests but as part of a structured plan to determine candidacy and procedural strategy. For many international patients, preliminary review of reports and imaging before travel can help clarify whether an in-person intervention workup is appropriate.

Another practical consideration is communication. International patient services support scheduling, medical record coordination, travel planning, and language assistance in more than 20 languages. For patients and families arriving in a new country while making complex medical decisions, this administrative and linguistic support can reduce confusion and help them focus on the clinical discussion. It does not replace medical care, but it can make specialized care easier to navigate.

Personalized treatment planning is especially important in mitral valve disease. Two patients can both be told they have severe mitral regurgitation yet need very different treatments because their valve anatomy, ventricular function, age, and coexisting illnesses differ substantially. Acibadem’s approach is designed around that reality: define the mechanism of the leak carefully, assess procedural feasibility, optimize the patient medically, and then recommend the treatment path that is most appropriate for that individual case.

Taking the Next Step

If you or a family member has been told that the mitral valve is leaking and symptoms are getting worse, it is reasonable to ask whether a less invasive repair may be possible. MitraClip can be an important option for carefully selected patients, particularly when open-heart surgery carries added risk or when heart failure and valve disease are closely linked. The key first step is not deciding on a procedure alone, but obtaining an expert assessment of the valve, the heart, and the full clinical picture.

If you would like to understand whether MitraClip may be appropriate, you may request a consultation or a second opinion. A detailed review of your echocardiogram, medical history, current symptoms, and prior treatments can help clarify your options and the next best step in care.

This information is intended for general educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment.